Literature DB >> 2905062

Inhibition of growth hormone-stimulated lipolysis by somatostatin, insulin, and insulin-like growth factors (somatomedins) in vitro.

R M Campbell1, C G Scanes.   

Abstract

The effects of somatostatin, insulin, insulin-like growth factor I (IGF-I), and insulin-like growth factor II (IGF-II)/MSA on growth hormone (GH) (1 microgram/ml)-induced lipolysis were examined employing chicken adipose tissue in vitro. Basal and GH-stimulated glycerol release were inhibited by somatostatin (1 ng/ml) and by IGF-II/MSA (10 and 100 ng/ml). Insulin and IGF-I (10 and 100 ng/ml) completely inhibited the lipolytic response to GH without affecting basal glycerol release. Insulin and IGF-I were equipotent in inhibiting GH-induced lipolysis while IGF-II is only 16% as potent as insulin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905062     DOI: 10.3181/00379727-189-42819

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  6 in total

1.  Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults.

Authors:  P A Velasquez-Mieyer; P A Cowan; K L Arheart; C K Buffington; K A Spencer; B E Connelly; G W Cowan; R H Lustig
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

2.  Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.

Authors:  Diana Cruz-Topete; Jens Otto L Jorgensen; Britt Christensen; Lucila Sackmann-Sala; Thomas Krusenstjerna-Hafstrøm; Adam Jara; Shigeru Okada; John J Kopchick
Journal:  J Clin Endocrinol Metab       Date:  2011-05-04       Impact factor: 5.958

3.  Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study.

Authors:  Pouneh K Fazeli; Elizabeth A Lawson; Rajani Prabhakaran; Karen K Miller; Daniel A Donoho; David R Clemmons; David B Herzog; Madhusmita Misra; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2010-07-28       Impact factor: 5.958

Review 4.  Limiting factors for milk production in dairy cows: perspectives from physiology and nutrition.

Authors:  Josef J Gross
Journal:  J Anim Sci       Date:  2022-03-01       Impact factor: 3.159

Review 5.  Use of somatostatin analogues in obesity.

Authors:  Themistoklis Tzotzas; Kostas Papazisis; Petros Perros; Gerasimos E Krassas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity.

Authors:  Ujendra Kumar; Sneha Singh
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.